Ir para o conteúdo principal

Australia Últimas notícias

Todas as matérias desta categoria, das mais recentes às mais antigas.

Bloomberg

US Had 'Very Good Day' Speaking With Iran, Vance Says

US Vice President JD Vance said talks with Iran over the weekend were "very, very good," as the sides attempt to reach a peace deal within two months and formally end a war. Vance says a key point was building a mechanism to keep the Strait of Hormuz open. He spoke to reporters in Emmen, Switzerland where talks are being held.

Leia mais: US Had 'Very Good Day' Speaking With Iran, Vance Says
Bloomberg

Lesley Marks and Katerina Simonetti on US-Iran Talks, Market Outlook

Mackenzie Investments chief investment officer Lesley Marks and Morgan Stanley private wealth advisor and senior portfolio manager Katerina Simonetti discusses the US and Iran nuclear talks, their market outlook following the SpaceX IPO. They spoke with Guy Johnson on June 19, 2026.

Leia mais: Lesley Marks and Katerina Simonetti on US-Iran Talks, Market Outlook
Bloomberg

Diversify Outside of 'AI Only Play' Says Mamadou-Abou Sarr

Wall Street traders drove stocks down from the brink of all-time highs as a renewed slide in SpaceX overshadowed optimism about progress in peace talks between the US and Iran. Mamadou-Abou Sarr, President & Co-Founder of V-Square Quantitative Management discusses the markets and how he is encouraging diversified investing.

Leia mais: Diversify Outside of 'AI Only Play' Says Mamadou-Abou Sarr
Bloomberg

AbbVie's Deal with Apogee; Regenxbio Moves on Gene Therapy Drug | Stock Movers

On this episode of Stock Movers with Nathan Hager: - Apogee (APGE) shares are soaring on news AbbVie is closing in on a nearly $11 billion deal to buy inflammatory disease drug developer Apogee Therapeutics. That's also according to a Financial Times report. - Regenxbio (RGNX) shares are moving on news Regenxbio aligned with the FDA on next steps for a potential accelerated approval of Navsunli, a gene therapy for Mucopolysaccharidosis II, with the FDA confirming the company doesn't need to conduct additional studies of the drug. - SpaceX (SPCX) is lower this morning, continuing its slide after its record IPO.

Leia mais: AbbVie's Deal with Apogee; Regenxbio Moves on Gene Therapy Drug | Stock Movers
Bloomberg

Remembering Alan Greenspan

Former Fed Governor Randy Kroszner joined Bloomberg Open Interest to break down Alan Greenspan's complicated legacy crediting him for fueling America's economic boom while acknowledging the risks that helped lead to the 2008 financial crisis. He also explains why the next era of the Federal Reserve could feature simpler communication and a renewed focus on long-term economic trends.

Leia mais: Remembering Alan Greenspan
Bloomberg

High AI Spending is 'Not Temporary' Says Everpure CFO Robbiati

Tarek Robbiati, CFO of data storage company Everpure, said that the increased capex spend on AI is 'not temporary' even if the industry supply and demand equation rebalances and more AI capacity becomes available. Robbiati said that while the AI market is expected to revert to a mean, it will not happen quickly and it may not go back to the same level.

Leia mais: High AI Spending is 'Not Temporary' Says Everpure CFO Robbiati